Literature DB >> 12389125

Immunohistochemical study of pro-apoptotic factors Bax, Fas and CPP32 in urinary bladder cancer: prognostic implications.

Ioanna Giannopoulou1, Lydia Nakopoulou, Anastasios Zervas, Andreas C Lazaris, Constandinos Stravodimos, Aris Giannopoulos, Panagiotis S Davaris.   

Abstract

Apoptosis is a process which can retard the progress of malignant tumours. In the present study we investigated the immunohistochemical expression of three pro-apoptotic proteins (Bax, Fas receptor and caspase 3 - CPP32) as well as the apoptotic index (TUNEL Index) in 53 urothelial carcinomas of the urinary bladder. We examined all possible relationships between these factors and clinicopathological variables, as well as the patients' disease free survival. All three markers, and in particular the Fas receptor, were detectable in a remarkable proportion of specimens, however, none of the markers examined was associated with any clinicopathological parameter. In multivariate statistical analysis, Bax emerged as an independent predictor of a favourable prognosis. It is noteworthy that none of the pro-apoptotic markers examined was directly linked with the apoptotic rate of the malignant cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12389125     DOI: 10.1007/s00240-002-0274-1

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  5 in total

Review 1.  Molecular substratification of bladder cancer: moving towards individualized patient management.

Authors:  Anirban P Mitra
Journal:  Ther Adv Urol       Date:  2016-03-28

2.  Pathobiology and chemoprevention of bladder cancer.

Authors:  Takuji Tanaka; Katsuhito Miyazawa; Tetsuya Tsukamoto; Toshiya Kuno; Koji Suzuki
Journal:  J Oncol       Date:  2011-09-15       Impact factor: 4.375

3.  Pro- and antiapoptotic markers in upper tract urothelial carcinoma associated with Balkan endemic nephropathy.

Authors:  Ljubinka Jankovic-Velickovic; Slavica Stojnev; Ana Ristic-Petrovic; Zana Dolicanin; Takanori Hattori; Kenichi Mukaisho; Mariola Stojanovic; Vladisav Stefanovic
Journal:  ScientificWorldJournal       Date:  2011-10-17

4.  Bax expression measured by AQUAnalysis is an independent prognostic marker in oral squamous cell carcinoma.

Authors:  Pinaki Bose; Alexander C Klimowicz; Elizabeth Kornaga; Stephanie K Petrillo; T Wayne Matthews; Shamir Chandarana; Anthony M Magliocco; Nigel T Brockton; Joseph C Dort
Journal:  BMC Cancer       Date:  2012-08-01       Impact factor: 4.430

5.  Prognostic impact of FAS/CD95/APO-1 in urothelial cancers: decreased expression of Fas is associated with disease progression.

Authors:  K Yamana; V Bilim; N Hara; T Kasahara; T Itoi; R Maruyama; T Nishiyama; K Takahashi; Y Tomita
Journal:  Br J Cancer       Date:  2005-09-05       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.